Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Jakobs

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cost Effectiveness and Resource Allocation : C/E|December 12, 2022
Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontierFlorian Jakobs, Julia Jeck, Paymon Ahmadi, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Retrospective modelling of hospital bed capacities associated with the administration of remdesivir during the first wave of COVID-19 in a German metropolitan cityJulia Jeck, Florian Jakobs, Anna Kron, et al.
Jac-Antimicrobial Resistance|June 21, 2023
Health-economic modelling of cost savings due to the use of rezafungin based on a German cost-of-illness study of candidiasisJulia Jeck, Florian Jakobs, Melina S Kurte, et al.
Infection|August 18, 2021
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic "first wave" in a German tertiary care hospitalJulia Jeck, Florian Jakobs, Anna Kron, et al.
BMC Health Services Research|September 9, 2021
A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in GermanyFlorian Jakobs, Sebastian Marcel Wingen-Heimann, Julia Jeck, et al.
Materials (Basel, Switzerland)|April 29, 2020
Homogeneous Distribution of Polymerizable Coumarin Dyes for Active Few Mode POFFlorian Jakobs, Kristoffer Harms, Jana Kielhorn, et al.
Polymers|July 18, 2019
Characterization of Double-Doped Polymer Optical Fibers as Luminescent Solar ConcentratorsItxaso Parola, M Asuncion Illarramendi, Florian Jakobs, et al.
European Journal of Haematology|August 29, 2023
Cost-effectiveness analysis of transplant-ineligible relapsed or refractory diffuse large B-cell lymphoma treatment options-Experience of the efficiency frontier approachMelina Sophie Kurte, Ann-Cathrine Siefen, Florian Jakobs, et al.
Mycoses|January 21, 2023
Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centreJulia Jeck, Sebastian M Wingen-Heimann, Florian Jakobs, et al.
Oncology Research and Treatment|September 21, 2020
Economic Impact of the Introduction of Outpatient Medical Specialist Care (ASV) of Gastrointestinal Cancer Patients from a German Hospital Management PerspectiveFlorian Jakobs, Ruben M W A Drost, Anna Kron, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cost Effectiveness and Resource Allocation : C/E|December 12, 2022
Health economic analysis of third-line interventions in diffuse large B-cell lymphomas in Germany: applying the efficiency frontierFlorian Jakobs, Julia Jeck, Paymon Ahmadi, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2021
Retrospective modelling of hospital bed capacities associated with the administration of remdesivir during the first wave of COVID-19 in a German metropolitan cityJulia Jeck, Florian Jakobs, Anna Kron, et al.
Jac-Antimicrobial Resistance|June 21, 2023
Health-economic modelling of cost savings due to the use of rezafungin based on a German cost-of-illness study of candidiasisJulia Jeck, Florian Jakobs, Melina S Kurte, et al.
Infection|August 18, 2021
A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic "first wave" in a German tertiary care hospitalJulia Jeck, Florian Jakobs, Anna Kron, et al.
BMC Health Services Research|September 9, 2021
A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in GermanyFlorian Jakobs, Sebastian Marcel Wingen-Heimann, Julia Jeck, et al.
Materials (Basel, Switzerland)|April 29, 2020
Homogeneous Distribution of Polymerizable Coumarin Dyes for Active Few Mode POFFlorian Jakobs, Kristoffer Harms, Jana Kielhorn, et al.
Polymers|July 18, 2019
Characterization of Double-Doped Polymer Optical Fibers as Luminescent Solar ConcentratorsItxaso Parola, M Asuncion Illarramendi, Florian Jakobs, et al.
European Journal of Haematology|August 29, 2023
Cost-effectiveness analysis of transplant-ineligible relapsed or refractory diffuse large B-cell lymphoma treatment options-Experience of the efficiency frontier approachMelina Sophie Kurte, Ann-Cathrine Siefen, Florian Jakobs, et al.
Mycoses|January 21, 2023
Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centreJulia Jeck, Sebastian M Wingen-Heimann, Florian Jakobs, et al.
Oncology Research and Treatment|September 21, 2020
Economic Impact of the Introduction of Outpatient Medical Specialist Care (ASV) of Gastrointestinal Cancer Patients from a German Hospital Management PerspectiveFlorian Jakobs, Ruben M W A Drost, Anna Kron, et al.
Pageof 2